Trial · NCT03214094
Adverse events45
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 45
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Drug eruption | Skin and subcutaneous tissue disorders | Vonoprazan 10 mg | 4 | 1,059 | |
| serious | Endocarditis | Infections and infestations | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Gangrene | Infections and infestations | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Pneumonia | Infections and infestations | Vonoprazan 10 mg | 3 | 1,059 | |
| serious | Sepsis | Infections and infestations | Vonoprazan 10 mg | 2 | 1,059 | |
| serious | Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg | 2 | 1,059 | |
| serious | Lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Rectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Renal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Carotid artery stenosis | Nervous system disorders | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Cerebral infarction | Nervous system disorders | Vonoprazan 10 mg | 2 | 1,059 | |
| serious | Dizziness | Nervous system disorders | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Motor neurone disease | Nervous system disorders | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Myelopathy | Nervous system disorders | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Cataract nuclear | Eye disorders | Vonoprazan 10 mg | 1 | 1,059 | |
| serious | Angina pectoris | Cardiac disorders | Vonoprazan 10 mg | 7 | 1,059 | |
| serious | Angina unstable | Cardiac disorders | Vonoprazan 10 mg | 2 | 1,059 | |
| serious | Atrioventricular block complete | Cardiac disorders | Vonoprazan 10 mg | 1 | 1,059 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03214094/events